McCann KE, Goldfarb SB, Traina TA, Regan MM, et al. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ Breast Cancer 2024;10:8.
PMID: 38242892